Testing Restarts
Lives Safely

The world has changed. People’s livelihoods and the health of the world may never be “as it was” pre-pandemic.

In these times we all need peace of mind: NanoParma™ provides rapid, easy-to-use, and accurate testing for COVID-19 screening and immune protection.

Let’s go travel, enjoy a meal, attend a game, and work safely again!

NanoParma™ Testing enables individuals to safely and conveniently self-test for COVID-19 immune protection.

Test at a workplace, an event, at home or anywhere! Results can be uploaded to ParmaPass™ where maps of COVID-19 “safe zones” can be found for any community you reside in or need to travel to. Let’s work together to create better health for everyone!

See how NanoParma™ can help restart lives safely.

Testing

Empowers

communities

Choose A Scenario:

WHY

SeraParma™

TESTING

RAPID

Fast and reliable results in only 20 minutes
Early detection and early intervention

EASY-TO-USE

Free from the fear of nasal and throat swabs
Results from Saliva/finger stick blood tests

ACCURATE

Over 99% of sensitivity and specificity

As accurate as the “Gold Standard" PCR testing

immune protection

Testing for SARS-CoV-2 neutralizing antibodies
The level of immunity against COVID-19

WHY

SeraParma™

TESTING

RAPID

Fast and reliable results in only 20 minutes
Early detection and early intervention

EASY-TO-USE

Free from the fear of nasal and throat swabs Results from either Saliva or Blood test

ACCURATE

Greater than 99% sensitivity and specificity
As accurate as “Gold Standard" PCR testing

immune protection

Testing for SARS-CoV-2 neutralizing antibodies
Tests for COVID-19 immunity

WHY

SeraParma™

TESTING

RAPID

Fast and reliable results in only 20 minutes
Early detection and early intervention

EASY-TO-USE

Free from the fear of nasal and throat swabs
Results from Saliva/finger stick blood tests

ACCURATE

Over 99% of sensitivity and specificity
As accurate as the PCR testing

immune protection

Testing for SARS-CoV-2 neutralizing antibodies
The level of immunity against COVID-19

NanoParma™ testing is an easy-to-use, rapid and accurate COVID-19 antibody testing system.

MucoParma™ tests saliva for IgA (infection) while SeraParma™ tests for IgM, IgG and neutralizing antibodies (immunity) using only a single drop of blood.

Types of    

NanoParma™  

Testing    

MucoParma™ COVID-19 IgA

IgA is a primary class of antibodies found in saliva, part of the mucosal membrane system. When someone is infected with SARS-CoV-2, IgA initially rises as early as IgM. By testing saliva IgA, MucoParma™ enables organizations and individuals to rapidly screen for infection with ease and convenience.

SeraParma™ COVID-19 IgM

IgM is a major class of antibodies produced by the immune system and circulated in the blood once someone is infected with SARS-CoV-2 virus. A positive IgM test indicates the body is currently infected and means the immune system is responding to COVID-19.

Usually, a lateral flow based rapid antibody test is not used for infection diagnoses due to its lack of sensitivity. However, SeraParma™ possesses 1,000 times higher sensitivity than conventional lateral flow technologies. The secret is in the nanoparticle. Data has shown 100% agreement between FDA validated results for PCR testing and those of SeraParma™ testing for COVID-19 IgM. Furthermore, by testing IgM, we get to know the precise status of a patient’s infection and/or immunity and are able to take the right action to help make communities safer.

E98630A8-6586-4B58-B8A5-3DFB3F12980B

SeraParma™ COVID-19 Neutralizing Antibodies

After recovery from COVID-19, IgG may remain in one’s blood circulation but it’s not guaranteed those antibodies are able to defend SARS-CoV-2 in the future. Similarly, after receiving a vaccine shot, it’s not guaranteed the antibodies produced by one’s immune system can defend future COVID-19. It takes specific neutralizing antibodies to defend cells from SARS-CoV-2 infection. Our testing of SeraParma™ COVID-19 Neutralizing Antibodies is to confirm the existence of the neutralizing antibodies that possess immune protection from COVID-19.

MucoParma™ COVID-19 IgA

IgA is a primary class of antibodies found in saliva, part of the mucosal membrane system. When someone is infected with SARS-CoV-2, IgA initially rises as early as IgM. By testing saliva IgA, MucoParma™ enables organizations and individuals to rapidly screen for infection with ease and convenience.

SeraParma™ COVID-19 IgM

IgM is a major class of antibodies produced by the immune system and circulated in the blood once someone is infected with SARS-CoV-2 virus. A positive IgM test indicates the body is currently infected and means the immune system is responding to COVID-19.

Usually, a lateral flow based rapid antibody test is not used for infection diagnoses due to its lack of sensitivity. However, SeraParma™ possesses 1,000 times higher sensitivity than conventional lateral flow technologies. The secret is in the nanoparticle.

Data has shown 100% agreement between FDA validated results for PCR testing and those of SeraParma™ testing for COVID-19 IgM. Furthermore, by testing IgM, we get to know the precise status of a patient’s infection and/or immunity and are able to take the right action to help make communities safer.

E98630A8-6586-4B58-B8A5-3DFB3F12980B

SeraParma™ COVID-19 Neutralizing Antibodies

After recovery from COVID-19, IgG may remain in one’s blood circulation but it’s not guaranteed those antibodies are able to defend SARS-CoV-2 in the future.

Similarly, after receiving a vaccine shot, it’s not guaranteed the antibodies produced by one’s immune system can defend against future infections.

SeraParma™ tests for specific SARS-CoV-2 Neutralizing Antibodies to confirm the existence of immune protection from COVID-19.



We all want the pandemic to be over. We all hope to get back to normal. But history has taught us that vaccination alone cannot single-handedly control a virus.

To avoid lockdown cycles experienced in 2020, we need to curb the spread of the virus using a three-pronged strategy: 1.Vaccinations, 2.Testing/Isolations, and
3.Safe Zone mapping strategies.

NanoParma™ provides innovative testing tools, and also a safe-zone mapping tool to complement the on-going vaccination efforts throughout the world.

Our open-source ParmaPass™ app generates time-stamped, blockchain verifiable certificates of immune status for anyone who has been tested and shared his/her testing results anonymously. Safety is on the way!

Our Team

Jesse Chih-Wei Lin

CEO

MT(ASCPi), MBA


BS in Medical Technology, National Taiwan University (NTU)

 

Co-founder of BioInnovation Taiwan

 

President of NTU MedTech Alumni Association

 

7+ years experience in MedTech startup business consulting

 

Young Taiwan Scholar for Global Health Forum in Taiwan (2017)

Howard Hong-wei yang

CTO

Professor at the Institute of Medical Science & Technology, National Sun-Yat-Sen University (NSYSU), Taiwan


Distinguished Young Scholar in NSYSU (2019-2022)


NIH Postdoctoral Fellow, Georgia Institute of Technology, USA (2013-
2014)

 

Outstanding Paper Award, Association of Chemical Sensors in Taiwan
(2017/2019/2020)


Project for Excellent Junior Research Investigators, Ministry of
Science and Technology (2017~2021)

erik wainwright

CMO

15+ years experience in cross culture communication

 

7+ years experience as executive life coach and marketing consulting

Co-founder of ASHERS LEAVEN

 

Founding member of BioInnovation Taiwan

 

Studied Sociology/ Social Psychology/ Cultural Anthropology at Washington State University

Marketing Group

Miya Wu
Anita Hsu
EJ Wu

R&D Group

Lancelot Lee
Hans pang
Emily hsu

MucoParma™ SARS-COV-2 IgA

IgA is the primary class of antibodies found in saliva, part of mucosal membrane system. When one is SARS-CoV-2 infected, IgA rises as early as IgM (ref). By testing saliva IgA, MucoParma™ enables individuals and business to screen infection rapidly.

SeraParma™ SARS-COV-2 IgM/IgG

IgM is the major class of antibodies produced by immune system and found in blood circulation when one is SARS-CoV-2 infected. A positive IgM test indicates a current COVID-19 and the immune system is responding it.

IgG is produced in COVID-19 patients within 7-10 days after infection. IgG usually remains in the blood after one recovers from the infection to protect one from future infection.

Usually, a lateral flow based rapid antibody test is not used for infection diagnosis due to its compromised sensitivity. However, SeraParma™ possesses 1,000 times higher sensitivity than the old lateral flow technology. Data showed 100% agreement between results of FDA validated PCR tests and SeraParma™ COVID-19 IgM/IgG. Furthermore, by testing IgM and IgG simultaneously, we get to know the status of one’s infection and take the right action.

E98630A8-6586-4B58-B8A5-3DFB3F12980B.jpeg

SeraParma™ COVID-19 Neutralizing Antibodies

After recovery from COVID-19, IgG may remain in one’s blood circulation but it’s not guaranteed those antibodies are able to defend SARS-CoV-2 in the future. Similarly, after receiving a vaccine shot, it’s not guaranteed the antibodies produced by one’s immune system can defend future COVID-19. It takes specific neutralizing antibodies to defend cells from SARS-CoV-2 infection. Our testing of SeraParma™ COVID-19 Neutralizing Antibodies is to confirm the existence of the neutralizing antibodies that possess immune protection from COVID-19.

Post-Pandemic, daily life isn’t the same. People everywhere face the threat of contracting the SARS-CoV-2 virus when leaving their homes and going outside, and this is stressful.

Today, because of COVID-19 people are facing uncertainty and loss. Changes are inevitable, yet humans everywhere want to live in good health. In times like this there's an increased attention to public health, including mental health.

We believe that things are going to get better. While things may never go back to the way they were before the pandemic, we envision bringing back a feeling of safety into our communities. In our vision people can hang out and relax with friends or family, have a meal at a favorite restaurant or attend a sporting event, doing daily life safely.

By implementing “safe zones” into the communities we are helping bring peace of mind back to the people. At NanoParma™ our mission is to achieve this reality! Better health isn’t far away!